title: Initial experience with a new fibrinolytic agent (APSAC) in patients with major pulmonary embolism.
authors.forename: J H
authors.initials: JH
authors.lastname: Bett
authors.forename: I H
authors.initials: IH
authors.lastname: Bunce
authors.forename: J F
authors.initials: JF
authors.lastname: Cade
authors.forename: A J
authors.initials: AJ
authors.lastname: Concannon
authors.forename: A
authors.initials: A
authors.lastname: Gallus
authors.forename: J
authors.initials: J
authors.lastname: Low
mesh_terms: D000368:Aged; D016255:Anistreplase; D002986:Clinical Trials as Topic; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D010958:Plasminogen / Q000627:therapeutic use*; D011655:Pulmonary Embolism / Q000097:blood / Q000188:drug therapy*; D013300:Streptokinase / Q000627:therapeutic use*
chemical_list: D016255:Anistreplase; D010958:Plasminogen; D013300:Streptokinase